Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis: Study Protocol for an Open, Uncontrolled Interventional Study, EXALS.

NCT06199284 is registered in ClinicalTrials.gov with Institut de Recherche sur la Moelle épinière et l'Encéphale as lead sponsor.

NCT NCT06199284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06199284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis: Study Protocol for an Open, Uncontrolled Interventional Study, EXALS.
Lead sponsor
Institut de Recherche sur la Moelle épinière et l'Encéphale
Phase
Not applicable
Overall status
Suspended
Start date
January 31, 2024
Completion date
January 29, 2027
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

als - amyotrophic lateral sclerosis